Get our Free Drug Patent Expiration Updates

Serving hundreds of leading biopharmaceutical companies globally:

Mallinckrodt
Farmers Insurance
Fish and Richardson
Fuji
UBS
Merck
US Department of Justice
QuintilesIMS
Chubb

Generated: February 22, 2019

DrugPatentWatch Database Preview

CLINICAL TRIALS PROFILE FOR LIQUID E-Z-PAQUE

« Back to Dashboard

Clinical Trials for Liquid E-z-paque

Trial ID Title Status Sponsor Phase Summary
NCT00000140 The Silicone Study Completed National Eye Institute (NEI) Phase 3 To compare, through a randomized, multicenter surgical trial, the postoperative tamponade effectiveness of intraocular silicone oil with that of an intraocular long-acting gas (initially sulfur hexafluoride [SF 6 ], later perfluoropropane [C 3 F 8 ]) for the management of retinal detachment complicated by proliferative vitreoretinopathy (PVR), using vitrectomy and associated techniques. To evaluate the ocular complications that result from the use of silicone oil and gas.
NCT00000302 Study Comparing Liquid and Tablet Buprenorphine Formulations - 5 Completed National Institute on Drug Abuse (NIDA) Phase 3 The purpose of this study is to compare liquid and tablet buprenorphine formulations.
NCT00000320 Buprenorphine Formulation Comparison: Sublingual Tablet vs. Solution - 1 Completed National Institute on Drug Abuse (NIDA) Phase 1/Phase 2 The purpose of this study is to compare subject response to liquid vs. tablet formulations, to assess bioequivalency of liquid vs. tablet, to compare subject preference, and to evaluate if dose response curve for tablet is equal to liquid form."
NCT00000341 Evaluation of Liquid vs. Tablet Buprenorphine - 6 Completed National Institute on Drug Abuse (NIDA) Phase 2 The purpose of this study is to evaluate the steady-state pharmacokinetics and bioavailability of buprenorphine sublingual tablets vs. sublingual solution.
Trial ID Title Status Sponsor Phase Summary

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

Clinical Trial Conditions for Liquid E-z-paque

Condition Name

Condition Name for Liquid E-z-paque
Intervention Trials
Healthy 61
Cystic Fibrosis 19
HIV Infections 18
Breast Cancer 18
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Condition MeSH

Condition MeSH for Liquid E-z-paque
Intervention Trials
Diabetes Mellitus 38
Infection 32
Diabetes Mellitus, Type 2 30
HIV Infections 25
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Locations for Liquid E-z-paque

Trials by Country

Trials by Country for Liquid E-z-paque
Location Trials
Canada 129
United Kingdom 83
Germany 66
France 54
Spain 51
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Trials by US State

Trials by US State for Liquid E-z-paque
Location Trials
California 123
Texas 105
Maryland 81
New York 78
Ohio 72
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Progress for Liquid E-z-paque

Clinical Trial Phase

Clinical Trial Phase for Liquid E-z-paque
Clinical Trial Phase Trials
Phase 4 182
Phase 3 126
Phase 2/Phase 3 26
[disabled in preview] 215
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Status

Clinical Trial Status for Liquid E-z-paque
Clinical Trial Phase Trials
Completed 559
Recruiting 172
Not yet recruiting 107
[disabled in preview] 63
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Sponsors for Liquid E-z-paque

Sponsor Name

Sponsor Name for Liquid E-z-paque
Sponsor Trials
National Cancer Institute (NCI) 67
M.D. Anderson Cancer Center 23
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) 22
[disabled in preview] 20
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Sponsor Type

Sponsor Type for Liquid E-z-paque
Sponsor Trials
Other 963
Industry 483
NIH 174
[disabled in preview] 12
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Farmers Insurance
Chubb
Fish and Richardson
Express Scripts
Chinese Patent Office
Boehringer Ingelheim
Covington
Accenture
Cantor Fitzgerald

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.